Preview

Medical Herald of the South of Russia

Advanced search

Approaches to managing patients with CIN in routine clinical practice

https://doi.org/10.21886/2219-8075-2020-11-4-92-98

Abstract

Objective: analyze the validity of destructive treatments for cervical diseases in clinical practice.

Materials and methods: analyzed archival medical documentation (medical records of an inpatient patient, form 003/y) of 258 patients who underwent surgical treatment of cervical diseases in 2017 – 2018. Statistical data were calculated on a personal computer using the Microsoft Excel 2011 for Mac program and the «Statistica» statistical program.

Results: an analysis of medical documentation revealed that a complete set of diagnostic methods, regulated by the clinical recommendations “Benign and precancerous cervical diseases from the perspective of cancer prevention” (2017), including HPV genotyping, was carried out in 28.7 % women. Before surgical treatment, a cytological examination of the cervix was carried out in 89.5 % cases, HPV-test — 31.4 % patients. As a result of the comparison of 258 histological and pre-operative clinical diagnoses, overdiagnosis of low- and high-grade cervical lesions (LSIL and HSIL) was noted in 16 (23.2 %) patients who did not have a history of childbirth and 42 (22.0 %) women who had previously given birth, which determined the use of destructive treatments without indications in 58 (22.5%) cases. An underestimation of the severity of cervical damage among unborn patients was found in 9 (13.0 %) patients, as well as in 40 (21.2 %) women with a history of childbirth.

Conclusions: overdiagnosis of the degree of intraepithelial cervical lesions entails the unreasonable use of destructive methods of treatment in young unborn women who violate the anatomic-functional integrity of the cervix and the architectonics of the cervical canal. 

About the Authors

V. G. Anufrieva
Rostov State Medical University
Russian Federation

Graduate student of the Department of obstetrics and gynecology №3,

Rostov-on-Don



E. Yu. Lebedenko
Rostov State Medical University
Russian Federation

Dr.Sci. (Med.), associate professor, professor of the Department of obstetrics and gynecology №3,

Rostov-on-Don



U. M. Magomedova
Rostov State Medical University
Russian Federation

Graduate student of the Department of obstetrics and gynecology №3,

Rostov-on-Don



A. F. Mikhelson
Rostov State Medical University
Russian Federation

Dr.Sci. (Med.), Professor, Honored Doctor of the Russian Federation head of the Department of obstetrics and gynecology №3,

Rostov-on-Don



References

1. Protasova A.E. Cervical Intraepithelial Neoplasia and Cervical Cancer. Is Human Papillomavirus the Only Risk. Effective pharmacotherapy. 2019; Vol. 15. №32: 42-46. (In Russ.) https://doi.org/10.33978/2307-3586-2019-15-32-42-46

2. N.M. Nazarova, V.N. Prilepskaya, K.I. Gusakov, E.G. Sycheva. HPV-Associated Diseases in Women and Men: Clinical and Practical Aspects. Meditsinskiy opponent=Medical opponent. 2018; 1(4): 22–28. (In Russ.) eLIBRARY ID: 36574688

3. Ashrafyan L.A. New drug strategy in the treatment of cervical neoplasias. Meditsinskiy opponent=Medical opponent 2019; 2(1): 10–16. (In Russ.) eLIBRARY ID: 36930681

4. Kyrgiou M, Mitra A, Arbyn M, Paraskevaidi M, Athanasiou A, Martin-Hirsch PPL, Bennett P, Paraskevaidis E. Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia. Cochrane Database of Systematic Reviews 2015, Issue 9. Art. No.: CD008478. https://doi.org/10.1002/14651858.CD008478.pub2

5. Kim M., Ishioka S., Endo T., Baba T., Saito T. Obstetrical prognosis of patients with cervical intraepithelial neoplasia (CIN) after «coin-shaped» conization // Arch. Gynecol. Obstet. 2016; Vol. 293 (3): 651-657. https://doi.org/10.1007/s00404-015-3860-5

6. Pokul L.V. Risk factors for cervical cancer // Journal of obstetrics and women's diseases. 2015; Т. 64; №6: 58-67. (In Russ.) https://doi.org/10.17816/JOWD64658-67

7. Levakov S.A., Kedrova A.G., Kozhurina E.V., Vanke N.S. Choice of treatment method for cervical dysplasia in women of reproducrive age. Effective pharmacotherapy. Obstetrics and gynecology. 2010; №3: 50-52. (In Russ.) LIBRARY ID: 21747175

8. Adams T.S., Mbatani N.H. Clinical management of women presenting with field effect of HPV and intraepithelial disease // Best Pract. Res. Clin. Obstet. Gynaecol. 2018; Vol. 47: 86-94. https://doi.org/10.1016/j.bpobgyn.2017.08.013

9. Liang Y., Chen M., Qin L., Wan B., Wang H. A meta-analysis of the relationship between vaginal microecology, human papillomavirus infection and cervical intraepithelial neoplasia // Infect. Agent. Cancer. 2019; Vol. 14: 29. https://doi.org/10.1186/s13027-019-0243-8

10. Yuldasheva D.Yu., Askarova U.J., Akhmedova G.A. Aggravating factors, contributing persistence of HPV in women with cervical interaepithelial neoplasia. Biology and integrative medicine. 2017; № 2: 55-63. (In Russ.) eLIBRARY ID: 28947771


Review

For citations:


Anufrieva V.G., Lebedenko E.Yu., Magomedova U.M., Mikhelson A.F. Approaches to managing patients with CIN in routine clinical practice. Medical Herald of the South of Russia. 2020;11(4):92-98. (In Russ.) https://doi.org/10.21886/2219-8075-2020-11-4-92-98

Views: 1227


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2219-8075 (Print)
ISSN 2618-7876 (Online)